← Back to all trials
Enrolling By Invitation
NCT07409194
The Effect of Acupressure on Hyperbilirubinemia in Newborns: A Randomized Controlled Trial
Conditions: Hyperbilirubinemia
Sex: All
Ages: 38 Weeks – 42 Months
Healthy volunteers: No
Phase: NA
Enrollment: 60
Sponsor: Yuzuncu Yil University
Location: Van Yuzuncu Yil University Van
Summary
This study is a randomized controlled trial conducted to evaluate the effect of acupressure application on hyperbilirubinemia in newborns. The study examined the effect of regular acupressure applications to specific points on serum bilirubin levels in newborns at risk of developing physiological jaundice in the first days of life. By comparing bilirubin levels between the experimental and control groups, the potential benefits of acupressure in reducing the severity of jaundice and supporting bilirubin metabolism were investigated. The findings suggest that acupressure can be used as a complementary method in neonatal care.
Eligibility Criteria
Inclusion Criteria:
* Gestational age ≥38 weeks
* Diagnosed with neonatal hyperbilirubinemia
* Hospitalized in the neonatal unit for at least 24 hours
* Birth weight ≥2500 g
* Written informed consent obtained from parents
Exclusion Criteria:
* Preterm newborns
* Congenital metabolic disease or congenital anomalies
* Hemodynamically unstable newborns
* Newborns whose parents did not provide consent
* Newborns with any condition preventing acupressure application
Source: ClinicalTrials.gov (NCT07409194). StuddyBuddy aggregates publicly available trial information.